Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 135-144

  Beck, Benjamin H ^a   Kim, Hyung Gyoon ^a   Kim, Hyunki ^b   Samuel, Sharon ^b   Liu, Zhiyong ^c   Shrestha, Robin ^a   Haines, Hilary ^d   Zinn, Kurt ^b   Lopez, Richard D ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c Kentucky   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

T cells; Cell therapy; Immunotherapy; Innate immunity

Indexed keywords

T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR ANTIGEN; INDIUM; LYMPHOCYTE ANTIGEN RECEPTOR; RADIOPHARMACEUTICAL AGENT;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER IMMUNOTHERAPY; CELL EXPANSION; CELL KILLING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MODEL; EX VIVO STUDY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INNATE IMMUNITY; ISOTOPE LABELING; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR LOCALIZATION; ADENOCARCINOMA; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER TRANSPLANTATION; CYTOTOXICITY; DIAGNOSTIC USE; FEMALE; HUMAN; IMMUNOLOGY; ISOGRAFT; KNOCKOUT MOUSE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INDIUM RADIOISOTOPES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLEEN; T-LYMPHOCYTE SUBSETS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 77953543076     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0527-6     Document Type: Article

References (42)

1. SM Alam JS Clark V Leech P Whitford WD George AM Campbell 1992 T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients Immunol Lett 31 279 283 10.1016/0165-2478(92)90127-A 1:STN:280:DyaK387pt1OjtA%3D%3D 1347754
2. CJ Aslakson FR Miller 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 1399 1405 1:STN:280:DyaK387nsVWmsA%3D%3D 1540948
3. I Bank M Book M Huszar Y Baram I Schnirer H Brenner 1993 V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors Clin Immunol Immunopathol 67 17 24 10.1006/clin.1993.1040 1:STN:280:DyaK3s7osFehtA%3D%3D 8443981 (Pubitemid 23100060)
4. J Bennouna E Bompas EM Neidhardt F Rolland I Philip C Galea S Salot S Saiagh M Audrain M Rimbert S Lafaye-de Micheaux J Tiollier S Negrier 2008 Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma Cancer Immunol Immunother 57 1599 1609 10.1007/s00262-008-0491-8 1:CAS:528:DC%2BD1cXhtVejsbnK 18301889
5. DJ Buchsbaum MB Khazaeli DB Axworthy J Schultz TR Chaudhuri KR Zinn M Carpenter AF LoBuglio 2005 Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein Clin Cancer Res 11 8180 8185 10.1158/1078-0432.CCR-05-0607 1:CAS:528:DC%2BD2MXht1entrzE 16299250 (Pubitemid 41698762)
6. A Cerwenka AB Bakker T McClanahan J Wagner J Wu JH Phillips LL Lanier 2000 Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice Immunity 12 721 727 10.1016/S1074-7613(00) 80222-8 1:CAS:528:DC%2BD3cXkslagurw%3D 10894171
7. Chaudhuri TR, Cao Z, Ponnazhagan S, Stargel A, Simhadri PL, Zhou T, Lobuglio AF, Buchsbaum DJ, Zinn KR (2004) Bioluminescence imaging of non-palpable breast cancer xenografts during treatment with TRA-8, an anti-DR5 antibody and chemotherapy [abstract]. In: Proceedings of the 95th Annual Meeting of the American Association for Cancer Research; 2004 March 27-31; Orlando, FL. Philadelphia (PA): AACR; 2004. p 481. Abstract no 2090
8. AJ Coito J Binder LF Brown M de Sousa L Van de Water JW Kupiec-Weglinski 1995 Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats J Immunol 154 2949 2958 1:CAS:528:DyaK2MXktlGhtL8%3D 7876561
9. S Cowey AA Szafran J Kappes KR Zinn GP Siegal RA Desmond H Kim L Evans RW Hardy 2007 Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice Clin Exp Metastasis 24 389 401 10.1007/s10585-007-9076-8 1:STN:280: DC%2BD2svivFOqtQ%3D%3D 17541709 (Pubitemid 47124938)
10. F Dieli N Gebbia F Poccia N Caccamo C Montesano F Fulfaro C Arcara MR Valerio S Meraviglia C Di Sano G Sireci A Salerno 2003 Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo Blood 102 2310 2311 10.1182/blood-2003-05-1655 1:CAS:528:DC%2BD3sXntlKrsbk%3D 12959943 (Pubitemid 37122416)
11. F Dieli D Vermijlen F Fulfaro N Caccamo S Meraviglia G Cicero A Roberts S Buccheri M D'Asaro N Gebbia A Salerno M Eberl AC Hayday 2007 Targeting human gamma}delta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer Cancer Res 67 7450 7457 10.1158/0008-5472. CAN-07-0199 1:CAS:528:DC%2BD2sXosVemtLY%3D 17671215 (Pubitemid 47206575)
12. M Girardi 2006 Immunosurveillance and immunoregulation by gammadelta T cells J Invest Dermatol 126 25 31 10.1038/sj.jid.5700003 1:CAS:528: DC%2BD28Xlt1Wjtbc%3D 16417214 (Pubitemid 43336090)
13. M Girardi AC Hayday 2005 Immunosurveillance by gammadelta T cells: focus on the murine system Chem Immunol Allergy 86 136 150 10.1159/000086658 1:CAS:528:DC%2BD2MXhtVensrzK 15976492
14. V Groh R Rhinehart H Secrist S Bauer KH Grabstein T Spies 1999 Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proc Natl Acad Sci USA 96 6879 6884 10.1073/pnas.96.12.6879 1:CAS:528:DyaK1MXks1Wktro%3D 10359807 (Pubitemid 29274978)
15. V Groh A Steinle S Bauer T Spies 1998 Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells Science 279 1737 1740 10.1126/science.279.5357.1737 1:CAS:528:DyaK1cXhvVers78%3D 9497295 (Pubitemid 28164472)
16. BL Guo KA Hollmig RD Lopez 2002 Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12 Cancer Immunol Immunother 50 625 637 10.1007/s00262-001-0244-4 1:CAS:528:DC%2BD38XhsVens7g%3D 11807626
17. BL Guo Z Liu WA Aldrich RD Lopez 2005 Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells Breast Cancer Res Treat 93 169 175 10.1007/s10549-005-4792-8 1:CAS:528:DC%2BD2MXhtVektLbI 16187237 (Pubitemid 41396778)
18. D Kabelitz D Wesch W He 2007 Perspectives of gammadelta T cells in tumor immunology Cancer Res 67 5 8 10.1158/0008-5472.CAN-06-3069 1:CAS:528: DC%2BD2sXisFWhsg%3D%3D 17210676 (Pubitemid 46142752)
19. D Kabelitz D Wesch E Pitters M Zoller 2004 Characterization of tumor reactivity of human V gamma 9 V delta 2 gamma delta T cells in vitro and in SCID mice in vivo J Immunol 173 6767 6776 1:CAS:528:DC%2BD2cXhtVShsb%2FJ 15557170
20. Y Ke K Pearce JP Lake HK Ziegler JA Kapp 1997 Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance J Immunol 158 3610 3618 1:CAS:528:DyaK2sXisFCitLk%3D 9103422
21. H Kim DE Morgan DJ Buchsbaum H Zeng WE Grizzle JM Warram CR Stockard LR McNally JW Long JC Sellers A Forero KR Zinn 2008 Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging Cancer Res 68 8369 8376 10.1158/0008-5472.CAN-08-1771 1:CAS:528:DC%2BD1cXht1Cmsb3J 18922909
22. MF Kircher J Grimm FK Swirski P Libby RE Gerszten JR Allport R Weissleder 2008 Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions Circulation 117 388 395 10.1161/CIRCULATIONAHA.107.719765 18172031
23. H Kobayashi Y Tanaka J Yagi Y Osaka H Nakazawa T Uchiyama N Minato H Toma 2007 Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study Cancer Immunol Immunother 56 469 476 10.1007/s00262-006-0199-6 1:CAS:528: DC%2BD2sXht1yhsLg%3D 16850345 (Pubitemid 46204533)
24. C Koenecke V Chennupati S Schmitz B Malissen R Forster I Prinz 2009 In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells Eur J Immunol 39 372 379 10.1002/eji.200838741 1:CAS:528:DC%2BD1MXitlCqu70%3D 19130484
25. V Kunzmann E Bauer J Feurle F Weissinger HP Tony M Wilhelm 2000 Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma Blood 96 384 392 1:CAS:528:DC%2BD3cXltVGht7c%3D 10887096
26. Z Liu IE Eltoum B Guo BH Beck GA Cloud RD Lopez 2008 Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer J Immunol 180 6044 6053 1:CAS:528:DC%2BD1cXkvVCjsLg%3D 18424725
27. Liu Z, Guo B, Lopez RD (2008) Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer. J Gastroenterol Hepatol 24:900-911
28. Z Liu BL Guo BC Gehrs L Nan RD Lopez 2005 Ex vivo expanded human Vgamma9 Vdelta 2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro J Urol 173 1552 1556 10.1097/01.ju.0000154355. 45816.0b 1:CAS:528:DC%2BD2MXjtFals74%3D 15821484 (Pubitemid 40524770)
29. RD Lopez S Xu B Guo RS Negrin EK Waller 2000 CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies Blood 96 3827 3837 1:CAS:528:DC%2BD3cXosVGntbs%3D 11090067
30. SR Mattarollo T Kenna M Nieda AJ Nicol 2007 Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity Cancer Immunol Immunother 56 1285 1297 10.1007/s00262-007-0279-2 1:CAS:528: DC%2BD2sXltlSks7k%3D 17265022 (Pubitemid 46763941)
31. N Meidenbauer J Marienhagen M Laumer S Vogl J Heymann R Andreesen A Mackensen 2003 Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients J Immunol 170 2161 2169 1:CAS:528:DC%2BD3sXht12hsrY%3D 12574389
32. S Ponnazhagan G Mahendra DT Curiel DR Shaw 2001 Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy J Virol 75 9493 9501 10.1128/JVI.75.19. 9493-9501.2001 1:CAS:528:DC%2BD3MXntVGqsLg%3D 11533211 (Pubitemid 32851951)
33. S Ponnazhagan G Mahendra S Kumar JA Thompson M Castillas Jr 2002 Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands J Virol 76 12900 12907 10.1128/JVI.76.24.12900- 12907.2002 1:CAS:528:DC%2BD38XptVynsrk%3D 12438615 (Pubitemid 35386973)
34. S Ponnazhagan P Mukherjee XS Wang K Qing DM Kube C Mah C Kurpad MC Yoder EF Srour A Srivastava 1997 Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation J Virol 71 8262 8267 1:CAS:528:DyaK2sXmvV2iu7s%3D 9343178
35. S Ponnazhagan KA Weigel SP Raikwar P Mukherjee MC Yoder A Srivastava 1998 Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes J Virol 72 5224 5230 1:CAS:528:DyaK1cXjtVehs7o%3D 9573295
36. S Salot C Laplace S Saiagh S Bercegeay I Tenaud A Cassidanius F Romagne B Dreno J Tiollier 2007 Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product J Immunol Methods 326 63 75 10.1016/j.jim.2007.07.010 1:CAS:528:DC%2BD2sXhtVWmtr3N 17716681 (Pubitemid 47361198)
37. H Sicard T Al Saati G Delsol JJ Fournie 2001 Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma Mol Med 7 711 722 1:CAS:528:DC%2BD3MXpt12lu7w%3D 11713370
38. H Sicard S Ingoure B Luciani C Serraz JJ Fournie M Bonneville J Tiollier F Romagne 2005 In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model J Immunol 175 5471 5480 1:CAS:528:DC%2BD2MXhtVyltr%2FO 16210655
39. D Simoni N Gebbia FP Invidiata M Eleopra P Marchetti R Rondanin R Baruchello S Provera C Marchioro M Tolomeo L Marinelli V Limongelli E Novellino A Kwaasi J Dunford S Buccheri N Caccamo F Dieli 2008 Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism J Med Chem 51 6800 6807 10.1021/jm801003y 1:CAS:528: DC%2BD1cXht1Ojtb%2FO 18937434
40. K Tao M Fang J Alroy GG Sahagian 2008 Imagable 4T1 model for the study of late stage breast cancer BMC Cancer 8 228 10.1186/1471-2407-8-228 18691423
41. H Tokuyama T Hagi SR Mattarollo J Morley Q Wang H Fai-So F Moriyasu M Nieda AJ Nicol 2008 V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs-rituximab and trastuzumab Int J Cancer 122 2526 2534 10.1002/ijc.23365 1:CAS:528:DC%2BD1cXltlaiu74%3D 18307255 (Pubitemid 351590486)
42. M Wilhelm V Kunzmann S Eckstein P Reimer F Weissinger T Ruediger HP Tony 2003 Gammadelta T cells for immune therapy of patients with lymphoid malignancies Blood 102 200 206 10.1182/blood-2002-12-3665 1:CAS:528: DC%2BD3sXltFemurk%3D 12623838 (Pubitemid 36759655)